• Treatments and Therapies

  Mylan Launches 1st Generic of Adcirca to Treat PAH

  Posted by pulmonary-hypertension-news-moderator on August 24, 2018 at 6:46 pm

  Mylan has launched 20 mg tadalafil tablets in the U.S., the first generic version of Adcirca, for patients with pulmonary arterial hypertension. Read more here.

  Have you ever been treated with Tafalafil? What do you think of this news?

  replied 5 years, 8 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply